🕵️ Inspiremd, Inc. ($NSPR)
SEC insider & ownership activity, last 12 months · CIK 1433607 · every row links its SEC filing
Insider sell value was withheld pending verification over the last 12 months. One red-flag 8-K in the window: Delisting notice (3.01), Jul 17, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
4 buyers, $421K (15 lots) · 1 seller, value withheld pending verification (24 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Gleason Shane Thomas | 0 | – | 24 | value withheld pending verification | May 19, 2026 |
| Stuka Paul | 11 | $187K | 0 | – | May 27, 2026 |
| Gary S. Roubin | 1 | $106K | 0 | – | May 7, 2026 |
| Scott R. Ward | 2 | $103K | 0 | – | May 7, 2026 |
| Slosman Marvin | 1 | $25K | 0 | – | May 12, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Wilmot B. Harkey | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Daniel Mack | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Marshall WACE, LLP | 10.0% | 13G | Nov 14, 2025 | filing ↗ | |
| Rosalind Advisors, Inc. | 9.2% | 13G | Feb 11, 2026 | filing ↗ | |
| Salamon Steven A. J. | 9.2% | 13G | Feb 11, 2026 | filing ↗ | |
| Aharon Gil | 9.2% | 13G | Feb 11, 2026 | filing ↗ | |
| Michael A. Lawless | 8.6% | 13D | Jun 26, 2025 | filing ↗ | |
| Rosalind Master Fund L.P. | 8.3% | 13G | Feb 11, 2026 | filing ↗ | |
| Aberdeen Group PLC | 7.5% | 13G | Feb 2, 2026 | filing ↗ | |
| Abrdn Inc. | 7.5% | 13G | Feb 2, 2026 | filing ↗ | |
| Orbimed Advisors LLC | 7.4% | 13G | Feb 17, 2026 | filing ↗ | |
| OrbiMed Capital GP IX LLC | 6.8% | 13G | Feb 17, 2026 | filing ↗ | |
| Parkman Healthcare Partners LLC | 5.8% | 13G | Nov 14, 2025 | filing ↗ | |
| Parkman Healthcare Partners Holdings LP | 5.8% | 13G | Nov 14, 2025 | filing ↗ | |
| Parkman Healthcare Partners Holdings GP LLC | 5.8% | 13G | Nov 14, 2025 | filing ↗ | |
| Martinez Gregory | 5.8% | 13G | Nov 14, 2025 | filing ↗ | |
| Nantahala Capital Partners Limited Partnership | 5.7% | 13G | Nov 14, 2025 | filing ↗ | |
| Marvin Slosman | 5.2% | 13D | Jan 22, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 23, 2026 | filing ↗ |
| Delisting notice (3.01) | Jul 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 3, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Earnings (2.02) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 1, 2026 | filing ↗ |
| Other events (8.01) | May 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 1, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 3, 2026 | filing ↗ |
| Other events (8.01) | Apr 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 3, 2026 | filing ↗ |
| Earnings (2.02) | Mar 18, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 17, 2025 | filing ↗ |